TY - JOUR AU - Farmer, P. AU - Frenk, J. AU - Knaul, F. M. AU - Shulman, L. N. AU - Alleyne, G. AU - Armstrong, L. AU - Atun, R. AU - Blayney, D. AU - Chen, L. AU - Feachem, R. PY - 2010 DA - 2010// TI - Expansion of cancer care and control in countries of low and middle income: a call to action JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)61152-X DO - 10.1016/S0140-6736(10)61152-X ID - Farmer2010 ER - TY - JOUR AU - Kachroo, S. AU - Etzel, C. J. PY - 2009 DA - 2009// TI - Decreasing the cancer burden in developing countries: concerns and recommendations JO - Eur J Cancer Care VL - 18 UR - https://doi.org/10.1111/j.1365-2354.2008.00985.x DO - 10.1111/j.1365-2354.2008.00985.x ID - Kachroo2009 ER - TY - JOUR AU - Stuckler, D. PY - 2008 DA - 2008// TI - Population causes and consequences of leading chronic diseases: a comparative analysis of prevailing explanations JO - Milbank Q VL - 86 UR - https://doi.org/10.1111/j.1468-0009.2008.00522.x DO - 10.1111/j.1468-0009.2008.00522.x ID - Stuckler2008 ER - TY - JOUR AU - Kanavos, P. PY - 2006 DA - 2006// TI - The rising burden of cancer in the developing world JO - Ann Oncol VL - 17 ID - Kanavos2006 ER - TY - JOUR PY - 2010 DA - 2010// TI - Scaling up cancer diagnosis and treatment in developing countries: what can we learn from the HIV/AIDS epidemic? JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq055 DO - 10.1093/annonc/mdq055 ID - ref5 ER - TY - JOUR AU - Orem, J. AU - Wabinga, H. PY - 2009 DA - 2009// TI - The roles of national cancer research institutions in evolving a comprehensive cancer control program in a developing country: experience from Uganda JO - Oncology VL - 77 UR - https://doi.org/10.1159/000259258 DO - 10.1159/000259258 ID - Orem2009 ER - TY - JOUR AU - Gustavsen, K. AU - Hanson, C. PY - 2009 DA - 2009// TI - Progress in public-private partnerships to fight neglected diseases JO - Health Aff VL - 28 UR - https://doi.org/10.1377/hlthaff.28.6.1745 DO - 10.1377/hlthaff.28.6.1745 ID - Gustavsen2009 ER - TY - JOUR AU - Sturchio, J. L. PY - 2001 DA - 2001// TI - The case of ivermectin: lessons and implications for improving access to care and treatment in developing countries JO - Community Eye Health VL - 14 ID - Sturchio2001 ER - TY - BOOK AU - Chirac, P. PY - 2002 DA - 2002// TI - Increasing the access to antiretrovial drugs to moderate the impacts of AIDS: an exploration of alternative options. AIDS, Public Policy and Child Well-being ID - Chirac2002 ER - TY - JOUR AU - Wertheimer, A. I. AU - Santella, T. M. AU - Lauver, H. J. PY - 2004 DA - 2004// TI - Successful public/private donation programs: a review of the Diflucan Partnership Program in South Africa JO - J Int Assoc Physicians AIDS Care (Chic) VL - 3 UR - https://doi.org/10.1177/154510970400300302 DO - 10.1177/154510970400300302 ID - Wertheimer2004 ER - TY - JOUR AU - Kanavos, P. AU - Vandoros, S. AU - Garcia-Gonzalez, P. PY - 2009 DA - 2009// TI - Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP JO - Glob Heal VL - 5 UR - https://doi.org/10.1186/1744-8603-5-19 DO - 10.1186/1744-8603-5-19 ID - Kanavos2009 ER - TY - JOUR AU - Mellstedt, H. PY - 2006 DA - 2006// TI - Cancer initiatives in developing countries JO - Ann Oncol VL - 17 ID - Mellstedt2006 ER - TY - JOUR AU - Reeler, A. V. AU - Mellstedt, H. PY - 2006 DA - 2006// TI - Cancer in developing countries: challenges and solutions JO - Ann Oncol VL - 17 ID - Reeler2006 ER - TY - JOUR AU - Cecchini, G. AU - Paganini, G. AU - D'Amico, M. AU - Cannone, M. AU - Bertuletti, C. AU - Barberis, M. C. PY - 2009 DA - 2009// TI - Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country JO - Pathologica VL - 101 ID - Cecchini2009 ER - TY - JOUR AU - Sepulveda, C. AU - Prado, R. PY - 2005 DA - 2005// TI - Effective cervical cytology screening programmes in middle-income countries: the Chilean experience JO - Cancer Detect Prev VL - 29 UR - https://doi.org/10.1016/j.cdp.2005.07.001 DO - 10.1016/j.cdp.2005.07.001 ID - Sepulveda2005 ER - TY - JOUR AU - Dye, T. D. AU - Bogale, S. AU - Hobden, C. AU - Tilahun, Y. AU - Hechter, V. AU - Deressa, T. AU - Bize, M. AU - Reeler, A. PY - 2010 DA - 2010// TI - Complex care systems in developing countries: breast cancer patient navigation in Ethiopia JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.24776 DO - 10.1002/cncr.24776 ID - Dye2010 ER - TY - JOUR AU - Guilhot, F. PY - 2004 DA - 2004// TI - Indications for imatinib mesylate therapy and clinical management JO - Oncologist VL - 9 UR - https://doi.org/10.1634/theoncologist.9-3-271 DO - 10.1634/theoncologist.9-3-271 ID - Guilhot2004 ER - TY - JOUR AU - Corm, S. AU - Micol, J. AU - Leroyer, A. AU - Daudignon, A. AU - Preudhomme, C. AU - Poulain, S. AU - Bregman, B. AU - Oukessou, A. AU - Lai, J. AU - Facon, T. PY - 2008 DA - 2008// TI - Kinetic of chronic myeloid leukaemia (CML) prevalence in Northern France since the introduction of imatinib JO - J Clin Oncol VL - 26 ID - Corm2008 ER - TY - JOUR AU - Rohrbacher, M. AU - Hasford, J. PY - 2009 DA - 2009// TI - Epidemiology of chronic myeloid leukaemia (CML) JO - Best Pract Res Clin Haematol VL - 22 UR - https://doi.org/10.1016/j.beha.2009.07.007 DO - 10.1016/j.beha.2009.07.007 ID - Rohrbacher2009 ER - TY - JOUR AU - Hochhaus, A. AU - Druker, B. AU - Sawyers, C. AU - Guilhot, F. AU - Schiffer, C. A. AU - Cortes, J. AU - Niederwieser, D. W. AU - Gambacorti-Passerini, C. AU - Stone, R. M. AU - Goldman, J. PY - 2008 DA - 2008// TI - Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-07-103523 DO - 10.1182/blood-2007-07-103523 ID - Hochhaus2008 ER - TY - JOUR AU - Hochhaus, A. AU - O'Brien, S. G. AU - Guilhot, F. AU - Druker, B. J. AU - Branford, S. AU - Foroni, L. AU - Goldman, J. M. AU - Muller, M. C. AU - Radich, J. P. AU - Rudoltz, M. PY - 2009 DA - 2009// TI - Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia JO - Leukemia VL - 23 UR - https://doi.org/10.1038/leu.2009.38 DO - 10.1038/leu.2009.38 ID - Hochhaus2009 ER - TY - JOUR AU - Lassarat, S. AU - Jootar, S. PY - 2006 DA - 2006// TI - Ongoing challenges of a global international patient assistance program JO - Ann Oncol VL - 17 ID - Lassarat2006 ER - TY - JOUR AU - Kiarie, G. W. AU - Othieno-Abinya, N. A. AU - Riyat, M. S. PY - 2009 DA - 2009// TI - The GLIVEC international patient assistance programme: the Nairobi experience JO - East Afr Med J VL - 86 ID - Kiarie2009 ER - TY - JOUR AU - Kantarjian, H. M. AU - Hochhaus, A. AU - Saglio, G. AU - De Souza, C. AU - Flinn, I. W. AU - Stenke, L. AU - Goh, Y. T. AU - Rosti, G. AU - Nakamae, H. AU - Gallagher, N. J. PY - 2011 DA - 2011// TI - Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70201-7 DO - 10.1016/S1470-2045(11)70201-7 ID - Kantarjian2011 ER - TY - JOUR AU - Reichardt, P. AU - Montemurro, M. PY - 2011 DA - 2011// TI - Clinical experience to date with nilotinib in gastrointestinal stromal tumors JO - Semin Oncol VL - 38 UR - https://doi.org/10.1053/j.seminoncol.2011.01.015 DO - 10.1053/j.seminoncol.2011.01.015 ID - Reichardt2011 ER - TY - JOUR AU - Italiano, A. AU - Cioffi, A. AU - Coco, P. AU - Maki, R. G. AU - Schoffski, P. AU - Rutkowski, P. AU - Le Cesne, A. AU - Duffaud, F. AU - Adenis, A. AU - Isambert, N. PY - 2011 DA - 2011// TI - Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib JO - Ann Surg Oncol VL - 71 ID - Italiano2011 ER - TY - JOUR AU - Montemurro, M. AU - Schoffski, P. AU - Reichardt, P. AU - Gelderblom, H. AU - Schutte, J. AU - Hartmann, J. T. AU - Von Moos, R. AU - Seddon, B. AU - Joensuu, H. AU - Wendtner, C. M. PY - 2009 DA - 2009// TI - Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2009.04.030 DO - 10.1016/j.ejca.2009.04.030 ID - Montemurro2009 ER - TY - JOUR AU - Garnock-Jones, K. P. PY - 2011 DA - 2011// TI - Nilotinib: in the first-line treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia in chronic phase JO - Drugs VL - 71 UR - https://doi.org/10.2165/11207770-000000000-00000 DO - 10.2165/11207770-000000000-00000 ID - Garnock-Jones2011 ER - TY - JOUR AU - Mathers, C. D. AU - Loncar, D. PY - 2006 DA - 2006// TI - Projections of global mortality and burden of disease from 2002 to 2030 JO - PLoS Med VL - 3 UR - https://doi.org/10.1371/journal.pmed.0030442 DO - 10.1371/journal.pmed.0030442 ID - Mathers2006 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/13/304/prepub UR - http://www.biomedcentral.com/1472-6963/13/304/prepub ID - ref30 ER -